BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19515280)

  • 21. Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment.
    Pittock SJ; Palace J
    Handb Clin Neurol; 2016; 133():165-83. PubMed ID: 27112677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Movement disorder emergencies in childhood.
    Kirkham FJ; Haywood P; Kashyape P; Borbone J; Lording A; Pryde K; Cox M; Keslake J; Smith M; Cuthbertson L; Murugan V; Mackie S; Thomas NH; Whitney A; Forrest KM; Parker A; Forsyth R; Kipps CM
    Eur J Paediatr Neurol; 2011 Sep; 15(5):390-404. PubMed ID: 21835657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumors masquerading as neurological diseases: A caution for clinicians in planning diagnosis and treatment.
    Vidhya Annapoorni CS; Retnaswami CS; Mailankody P; Katragadda P; Pillai SK; Rangarajan A; Padmanabha H; Pendharkar H
    Neurol India; 2020; 68(2):368-372. PubMed ID: 32415012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female.
    Lesher AP; Myers TJ; Tecklenburg F; Streck CJ
    J Pediatr Surg; 2010 Jul; 45(7):1550-3. PubMed ID: 20638543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Opsoclonus myoclonus with ataxia].
    Asher I; Elbirt D; Kushnir M; Sthoeger ZM
    Harefuah; 2005 Mar; 144(3):163-7, 232. PubMed ID: 15844453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinsonism in autoimmune diseases.
    Barba C; Alexopoulos H
    Int Rev Neurobiol; 2019; 149():419-452. PubMed ID: 31779823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
    Storstein A; Vedeler CA
    Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic disorders of the central and peripheral nervous systems.
    Didelot A; Honnorat J
    Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.
    Bataller L; Dalmau J
    Semin Neurol; 2003 Jun; 23(2):215-24. PubMed ID: 12894387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune Neurology of the Central Nervous System.
    Tobin WO; Pittock SJ
    Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):627-653. PubMed ID: 28570322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple paraneoplastic syndromes occurring in the same patient: clinical, imaging and neuro-pathological documentation].
    Sá G; Correia C; Pires M; Lopes G
    Acta Med Port; 2006; 19(6):489-93. PubMed ID: 17583609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment.
    Chirra M; Marsili L; Gallerini S; Keeling EG; Marconi R; Colosimo C
    Eur J Intern Med; 2019 Sep; 67():14-23. PubMed ID: 31200996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis.
    Baizabal-Carvallo JF; Stocco A; Muscal E; Jankovic J
    Mov Disord; 2013 Apr; 28(4):543-7. PubMed ID: 23400857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic movement disorders.
    Popławska-Domaszewicz K; Florczak-Wyspiańska J; Kozubski W; Michalak S
    Rev Neurosci; 2018 Sep; 29(7):745-755. PubMed ID: 29561731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuro-ophthalmologic manifestations of paraneoplastic syndromes.
    Ko MW; Dalmau J; Galetta SL
    J Neuroophthalmol; 2008 Mar; 28(1):58-68. PubMed ID: 18347462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic results in three cases of ganglioneuroblastoma associated with opsoclonus myoclonus ataxia syndrome.
    Shtarbanov IA; Boronsuzov IK; Chakarov IR; Konstantinov DN
    Indian J Cancer; 2020; 57(2):216-218. PubMed ID: 31898588
    [No Abstract]   [Full Text] [Related]  

  • 38. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
    Ovadia H; Karussis D; Abramsky O
    Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood.
    Zhou J; Jin M; Su Y; Zhuo X; Fu L; Ren X; Ren C; Zhou A; Li J; Zhang W
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200242. PubMed ID: 38657195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of acute movement disorders in children.
    Dale RC; Singh H; Troedson C; Pillai S; Gaikiwari S; Kozlowska K
    Dev Med Child Neurol; 2010 Aug; 52(8):739-48. PubMed ID: 20163436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.